LEADER 05649nam 2200841Ia 450 001 9910807468003321 005 20200520144314.0 010 $a0-429-09286-5 010 $a1-4200-4526-1 035 $a(CKB)2440000000014930 035 $a(EBL)3059669 035 $a(OCoLC)922955687 035 $a(SSID)ssj0000389697 035 $a(PQKBManifestationID)11246088 035 $a(PQKBTitleCode)TC0000389697 035 $a(PQKBWorkID)10449560 035 $a(PQKB)10001048 035 $a(SSID)ssj0000389698 035 $a(PQKBManifestationID)11938201 035 $a(PQKBTitleCode)TC0000389698 035 $a(PQKBWorkID)10448433 035 $a(PQKB)10662347 035 $a(MiAaPQ)EBC3059669 035 $a(MiAaPQ)EBC1398211 035 $a(Au-PeEL)EBL3059669 035 $a(CaPaEBR)ebr10231564 035 $a(CaONFJC)MIL787611 035 $a(OCoLC)1055657913 035 $a(OCoLC-P)1055657913 035 $a(FlBoTFG)9780429092862 035 $a(Au-PeEL)EBL1398211 035 $a(OCoLC)905983838 035 $a(OCoLC)1441737165 035 $a(FINmELB)ELB158459 035 $a(EXLCZ)992440000000014930 100 $a20071115d2008 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aModified-release drug delivery technology$hVolume 2 /$fedited by Michael J. Rathbone ... [et al.] 205 $a2nd ed. 210 $aNew York $cInforma Healthcare$dc2008 215 $a1 online resource (2 volumes) $cillustrations 225 1 $aDrugs and the pharmaceutical sciences ;$v184 311 0 $a1-84184-928-6 311 0 $a1-4200-5355-8 320 $aIncludes bibliographical references and indexes. 327 $a""Preface""; ""Contents""; ""Contributors""; ""1 The Modified-Release Drug Delivery Landscape""; ""2 The Modified-Release Drug Delivery Landscape""; ""3 The Modified-Release Drug Delivery Landscape""; ""4 The Modified-Release Drug Delivery Landscape""; ""5 Ophthalmic Drug Delivery""; ""6 Intraocular Implants for Controlled Drug Delivery""; ""7 Bioadhesive Ophthalmic Drug Inserts (BODI) for Veterinary Use""; ""8 Ion Exchange Resin Technology for Ophthalmic Applications""; ""9 Injections and Implants""; ""10 Long-Acting Protein Formulation-PLAD Technology"" 327 $a""11 Long-Term Controlled Delivery of Therapeutic Agents by the Osmotically Driven DUROS Implant""; ""12 The SABERTM Delivery System for Parenteral Administration""; ""13 Improving the Delivery of Complex Formulations Using the DepotOne Needle""; ""14 ReGel Depot Technology""; ""15 The Atrigel Drug Delivery System""; ""16 Enhancing Drug Delivery by Chemical Modification""; ""17 DepoFoam Multivesicular Liposomes for the Sustained Release of Macromolecules""; ""18 ALZAMER DepotTM Bioerodible Polymer Technology"" 327 $a""19 Pegylated Liposome Delivery of Chemotherapeutic Agents: Rationale and Clinical Benefit""; ""20 Dermal and Transdermal Drug Delivery""; ""21 ALZA Transdermal Drug Delivery Technologies""; ""22 Microneedles for Drug Delivery""; ""23 Transfersome: Self-Optimizing and Self-Driven Drug-Carrier, for Localized and Transdermal Drug Delivery""; ""24 Advances in Wound Healing""; ""25 Ultrasound-Mediated Transdermal Drug Delivery""; ""26 Lipid Nanoparticles with Solid Matrix for Dermal Delivery: Solid Lipid Nanoparticles and Nanostructured Lipid Carriers"" 327 $a""27 LidoSite-Vyteris Iontophoretic Technology""; ""28 Nail Delivery""; ""29 Immediate Topical Drug Delivery Using Natural Nano-Injectors""; ""30 DOT Matrix Technology""; ""31 The PassPortTM System: A New Transdermal Patch for Water-Soluble Drugs, Proteins, and Carbohydrates""; ""32 Nasal Drug Delivery""; ""33 Controlled Particle Dispersion: A Twenty-First-Century Nasal Drug Delivery Platform""; ""34 DirectHalerTM Nasal: Innovative Device and Delivery Method""; ""35 Intravaginal Drug Delivery Technologies""; ""36 Vaginal Rings for Controlled-Release Drug Delivery"" 327 $a""37 Phospholipids as Carriers for Vaginal Drug Delivery""; ""38 SITE RELEASE, Vaginal Bioadhesive System""; ""39 Clindamycin Vaginal Insert""; ""40 Bioresponsive Vaginal Delivery Systems""; ""41 Pulmonary Delivery of Drugs by Inhalation""; ""42 AERx Pulmonary Drug Delivery Systems""; ""43 Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols""; ""44 Adaptive Aerosol Delivery (AAD) Technology""; ""45 Nebulizer Technologies""; ""46 Formulation Challenges: Protein Powders for Inhalation"" ; ""47 The Respimat, a New Soft MistTM Inhaler for Delivering Drugs to the Lungs"" 330 $aThis two volume Second Edition describes the anatomical, physiological, pharmaceutical, and technological aspects of delivery routes. It also provides insight and critical assessment of the many available and emerging modified release drug delivery systems for their current and future value. 410 0$aDrugs and the pharmaceutical sciences ;$v184. 606 $aControlled release technology 606 $aControlled release preparations 606 $aDrug delivery systems 606 $aPharmaceutical technology 615 0$aControlled release technology. 615 0$aControlled release preparations. 615 0$aDrug delivery systems. 615 0$aPharmaceutical technology. 676 $a615/.19 701 $aRathbone$b Michael J.$f1957-$0318416 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910807468003321 996 $aModified-release drug delivery technology$94125831 997 $aUNINA